<DOC>
	<DOCNO>NCT01239706</DOCNO>
	<brief_summary>Prospective , Open Label , Cohort Study Traumatic Brain Injury Patients . The goal study assess safety NTx®-265 . NTx®-265 administer 9 day , patient follow additional 6 month .</brief_summary>
	<brief_title>Safety Study Human Chorionic Gonadotropin ( hCG ) Epoetin Alfa ( EPO ) Traumatic Brain Injury : Dosing Tier 1</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>1 . Male female patient age 1865 2 . Written inform consent legally acceptable representative 3 . Moderate severe traumatic brain injury ( TBI ) define Glasgow Coma motor ( GCSm ) score ≤5 , post resuscitation . 4 . Patient &lt; 48hours time injury first dose NTx™265 administer . 5 . Reasonable expectation availability receive full 9 day course therapy available follow evaluation 6 . Female patient either : 1 . Not childbearing potential , defined postmenopausal least 1 year surgically sterile ( bilateral oophorectomy hysterectomy ) 2 . If childbearing potential , would agree use two follow reliable method birth control throughout study , include followup visit : Condoms , sponge , foam , jelly , diaphragm intrauterine device A vasectomised partner Abstinence Note : Hormonal Based contraceptive NOT permissible one two form contraceptive study . 1 . Women test positive pregnancy , breastfeed use highly effective method birth control maintain duration study . 2 . Bilaterally fix pupil 3 . Serum hemoglobin &gt; 160g/L ( male ) &gt; 140g/L ( female ) ; platelet count &gt; 400,000/mm3 4 . Advanced cardiac , pulmonary , hepatic liver disease ; former operationally define use NCI Toxicity Criteria ( Grade 2 high ) . 5 . Suspected anoxic ischemic brain injury 6 . Known endocrine germ cell tumor 7 . Serum billirubin &gt; 1.5 x upper limit normal ( ULN ) . 8 . Alkaline Phosphatase &gt; 2.5 x ULN 9 . AST and/or ALT &gt; 2.5 x ULN 10 . Creatinine &gt; 2.0 x ULN 11 . Patients know documented transferrin saturation &lt; 20 % ferritin &lt; 100ng/mL . 12 . Male patient know documented elevate PSA level , PSA level ≥4ng/mL screen . 13 . Patients known history hypercoagulability , include know cardiolipin/antiphospholipid antibody syndrome . 14 . Allergy contraindication hCG include : 1 . Prior hypersensitivity hCG preparation one excipients . 2 . Primary ovarian failure . 3 . Uncontrolled thyroid adrenal dysfunction . 4 . An uncontrolled organic intracranial lesion pituitary tumor . 5 . Abnormal uterine bleeding undetermined origin . 6 . Ovarian cyst ovarian enlargement undetermined origin . 7 . Sex hormone dependent tumor reproductive organ , accessory sex gland , breast . 15 . Allergy contraindication epoetin alfa : 1. Who develop pure red cell aplasia follow treatment erythropoiesis regulate hormone . 2 . With uncontrolled hypertension 3 . With known hypersensitivity mammalian cellderived product , albumin ( human ) component product 4. Who reason receive adequate antithrombotic treatment 16 . A known diagnosis cancer ( except basal cell cancer ) . 17 . Uncontrolled hypertension , define blood pressure persistently 220 mm Hg systolic 120 mm Hg diastolic despite antihypertensive therapy . 18 . Use either hCG epoetin alfa within previous 90 day . 19 . Any condition know elevate hCG , active prior 24 month e.g. , choriocarcinoma germ cell tumor . 20 . Any patient live nursing home supervise living center . Patients must historically fully independent activity daily live include banking , shopping , cooking , toileting , shower dress . 21 . Any medical condition , investigator 's opinion , patient include trial . 22 . Patients take antiplatelet anticoagulant therapy . 23 . Preexisting active major psychiatric chronic Neurological disease . 24 . Patients history substance abuse dependency within 12 month prior study . 25 . Currently participate another investigational study 26 . Polytrauma define Abbreviated Injury Severity Score &gt; 3 area head . 27 . Patients evidence active previous thrombotic event . 28 . Patients contraindication MRI scan 29 . Patients currently take hormonal base contraceptive hormonal replacement therapy past three ( 3 ) month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>